SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

05 Aug 2022 Evaluate
Revenue showed a marginal decline at Rs. 1163.77 millions. For the quarter ended June 2022, as compared to corresponding quarter of last year.Net Profit recorded in the quarter ended June 2022 rise to 31.19% to Rs. 73.35  millions  compared to R. 55.91 millions in corresponding previous quarter.The company reported a good operating profit of 121.40 millions compared to 102.82 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1163.77 1172.72 -0.76 1163.77 1172.72 -0.76 4866.46 4319.60 12.66
Other Income 9.55 19.24 -50.36 9.55 19.24 -50.36 51.97 105.38 -50.68
PBIDT 121.40 102.82 18.07 121.40 102.82 18.07 520.43 551.22 -5.59
Interest 0.60 1.76 -65.91 0.60 1.76 -65.91 9.61 14.94 -35.68
PBDT 120.80 101.06 19.53 120.80 101.06 19.53 510.82 536.28 -4.75
Depreciation 24.18 29.91 -19.16 24.18 29.91 -19.16 119.60 150.76 -20.67
PBT 96.62 71.15 35.80 96.62 71.15 35.80 391.22 385.52 1.48
TAX 23.27 15.24 52.69 23.27 15.24 52.69 85.61 101.15 -15.36
Deferred Tax -1.33 -2.16 -38.43 -1.33 -2.16 -38.43 -9.95 6.50 -253.08
PAT 73.35 55.91 31.19 73.35 55.91 31.19 305.61 284.37 7.47
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 10.43 8.77 18.98 10.43 8.77 18.98 10.69 12.76 -16.20

Anuh Pharma Share Price

81.00 -0.10 (-0.12%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×